-
2024-516443-57-00
4
2023-10-11
Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh B, ALBI gr
-
2022-502160-20-00
5
2023-10-02
Idiopathic Immune Complex Mediated Membranoproliferative Glomeruloneph
-
2022-502157-33-00
7
2023-09-18
B-Cell Malignancies
-
2022-502019-12-00
5
2023-09-14
acute myeloid leukemia
-
2022-501831-18-00
4
2023-09-13
Patients with hematologic malignancies and undergoing allogenic hemato
-
2022-501810-77-00
5
2023-09-01
Relapsed or Refractory Marginal Zone Lymphoma
-
2022-500974-33-00
5
2023-08-12
acute venous thromboembolism event
-
2022-500933-10-00
11
2023-08-02
Preeclampsia during pregnancy
-
2024-519156-93-00
4
2023-07-21
Invasive mechanical ventilation expected to be required for more than
-
2024-513811-29-00
5
2023-07-03
Cardiogenic Shock
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2022-500218-25-01
6
2023-06-01
esophageal achalasia
-
2023-504263-16-00
5
2023-05-25
This is an extension study designed to provide continued treatment for
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2024-511936-28-00
1
2023-05-12
Relapsed/refractory hematological malignancies
or advanced/metastatic
-
2022-501124-23-00
5
2023-04-18
General anesthesia and sedative and anxiolytic sedation
-
2022-500085-96-00
5
2023-03-31
Patients with gambling disorder or sexual addiction or food addiction
-
2024-514929-33-00
5
2023-03-27
PANCREATIC FISTULA
-
2022-500520-30-00
5
2023-03-01
neurology
-
2024-513243-85-00
4
2023-02-03
Adult medulloblastoma
-
2024-516172-15-00
4
2023-02-03
Chronic Obstructive Pulmonary Disease
-
2023-505634-94-00
10
2023-02-02
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythe
-
2022-501335-16-00
10
2023-01-16
Interstitial lung disease
-
2024-514913-37-00
11
2023-01-12
Respiratory distress